✦ LIBER ✦

No increase of serum autoantibodies during therapy with recombinant human interferon-β1a in relapsing-remitting multiple sclerosis

✍ Scribed by Carlo Colosimo; Carlo Pozzilli; Marco Frontoni; Deborah Farina; Tatiana Koudriavtseva; Claudio Gasperini; Marco Salvetti; Guido Valesini

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

No increase of serum autoantibodies afte

✍ C. Colosimo; C. Pozzilli; D. Farina; E. Giugni; C. Gasperini; T. Koudriavtseva; 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 144 KB

A phase I clinical trial of human recomb

✍ J.I. Greenstein; R.L. Knobler; K.P. Johnson; S.G. Marcus; H.S. Panitch; F.D. Lub 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 35 KB

Incidence of exacerbations in the first

✍ Dr. Omar A. Khan; J. Richard Hebel 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 230 KB 👁 1 views

Magnetic resonance imaging outcome of ne

✍ Andrea Paolillo; S. Bastianello; Marco Frontoni; Claudio Gasperini; Elisabetta G 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 58 KB

Beneficial effect of interferon-β 1b tre

✍ Enrico Fainardi; Roberta Rizzo; Loredana Melchiorri; Massimiliano Castellazzi; V 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 154 KB

PS1-121 Effects of Interferon-β therapy

✍ F. Rizzo; M. Severa; E. Giacomini; R. Mechelli; V. Annibali; M. Salvetti; E.M. C 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB